UNH · News · 20260824N
Guidance / Outlook
UNITEDHEALTH GROUP INC · 2026-08-24 · Importance 57 · Surprise 60 · In source text
UnitedHealth Group raised its full-year 2026 adjusted EPS guidance to $19.50–$20.00 after reporting adjusted second-quarter EPS of $6.38. Third-party reporting said management reaffirmed expectations for mid-to-high single-digit revenue growth and double-digit earnings growth in 2026. The outlook reflects improved Optum profitability, margin repair, and a lower medical benefit ratio, although analysts continue to monitor regulatory and reimbursement pressure.
Key facts
- UnitedHealth Group raised its full-year 2026 EPS guidance to $19.50 to $20.00. source
- UnitedHealth Group reaffirmed its full-year 2026 guidance for mid-to-high single-digit revenue growth and double-digit earnings growth. source
- UnitedHealth shares rose 2.3% to $399.06 on August 24, 2026 (reported in the digest). source
- UnitedHealth was valued at 20.2 times its projected 2026 adjusted EPS (reported in the digest). source
- Analysts' average 12-month price target for UnitedHealth Group referenced in the digest is $455.92. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | positive | committed | — | UnitedHealth Group raised its full-year 2026 EPS guidance to $19.50 to $20.00. |
| revenue | positive | committed | — | UnitedHealth Group reaffirmed its full-year 2026 guidance for mid-to-high single-digit revenue growth and double-digit earnings growth. |
| net_income | positive | committed | — | UnitedHealth Group reaffirmed its full-year 2026 guidance for mid-to-high single-digit revenue growth and double-digit earnings growth. |